Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor Therapy

Background: Immune checkpoint inhibitors (ICIs) represent a new therapeutic standard for an increasing number of tumor entities. Nevertheless, individual response and outcome to ICI is very heterogeneous, and the identification of the ideal ICI candidate has remained one of the major issues. Sarcope...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Med
Main Authors: Loosen, Sven H., van den Bosch, Vincent, Gorgulho, Joao, Schulze-Hagen, Maximilian, Kandler, Jennis, Jördens, Markus S., Tacke, Frank, Loberg, Christina, Antoch, Gerald, Brümmendorf, Tim, Neumann, Ulf P., Kuhl, Christiane, Luedde, Tom, Roderburg, Christoph
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8036296/
https://ncbi.nlm.nih.gov/pubmed/33806224
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm10071361
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki